Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
35 (14%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-09-11 | 2021-01-14 | 124098 |
TEVA-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-10-01 | 2021-01-14 | 125500 |
TEVA-EVEROLIMUS | 2.5MG | TABLET | Resolved | 2020-10-01 | 2021-01-14 | 125503 |
ZADITEN | 1MG | TABLET | Resolved | 2020-11-06 | 2021-01-14 | 128010 |
TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2020-12-03 | 2021-01-14 | 129515 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-07 | 2021-01-14 | 131069 |
TEVA-LISINOPRIL/HCTZ (TYPE Z) | 20MG 25MG | TABLET | Resolved | 2021-01-07 | 2021-01-14 | 131090 |
TEVA-PROCTOSONE | 5MG 5MG 10MG 10MG | OINTMENT | Actual shortage | 2019-07-02 | 2021-01-14 | 88222 |
TEVA-PROCTOSONE | 5MG 5MG 10MG 10MG | OINTMENT | Actual shortage | 2019-07-02 | 2021-01-14 | 88225 |
TEVA-ACYCLOVIR | 400MG | TABLET | Actual shortage | 2020-08-20 | 2021-01-14 | 122712 |
TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2020-10-30 | 2021-01-21 | 127607 |
ACT AMLODIPINE | 10MG | TABLET | Resolved | 2020-11-06 | 2021-01-21 | 128034 |
RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2020-11-12 | 2021-01-21 | 128327 |
TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2020-11-19 | 2021-01-21 | 128609 |
TEVA-NARATRIPTAN | 1MG | TABLET | Resolved | 2020-11-19 | 2021-01-21 | 128632 |
TEVA-MEXILETINE | 200MG | CAPSULE | Resolved | 2020-12-17 | 2021-01-21 | 130285 |
TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-12-17 | 2021-01-21 | 130296 |
TEVA-ATAZANAVIR | 200MG | CAPSULE | Resolved | 2021-01-15 | 2021-01-21 | 131688 |
TEVA-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-12-17 | 2021-01-21 | 130291 |
TEVA-ANASTROZOLE | 1MG | TABLET | Resolved | 2020-01-24 | 2021-01-28 | 104374 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65017 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |